Home › Funds › UBS Group AG › ERNA
UBS Group AG position in ERNA
ERNEXA THERAPEUTICS INC · Health Care
Latest position (Q1 2026)21.23K sh
Reported value held$4.22K
Portfolio Weight0.00%
First reportedQ1 2023
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2023 | 3.86K | $13.14K | New |
| Q3 2023 | 105 | $229 | New |
| Q1 2024 | 741 | $1.78K | New |
| Q3 2024 | 83.62K | $87.80K | New |
| Q4 2024 | 16.86K | $4.96K | Reduce |
| Q1 2025 | 12.47K | $2.22K | Reduce |
| Q2 2025 | 548 | $1.01K | Reduce |
| Q4 2025 | 600 | $720 | New |
| Q1 2026 | 21.23K | $4.22K | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding ERNA
- Citadel Advisors 15.10K sh · $100.44K · Q2 2026
- Vanguard Group 35.92K sh · $43.11K · Q4 2025
- BlackRock Inc 33 sh · $219 · Q2 2026